|
⚲
|
| Keyboard |
| Maizel Ari
✚
|
|
|---|---|
| CIK # | 0002042289 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002042289] | |
| 4 | [0002042289] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Axsome Therapeutics Inc | |
| Maizel Ari |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Axsome Therapeutics Inc AXSM
Restricted Stock Units · derivative
|
2026-02-26 | Grant | 16,385 | $0.00 | |
|
Axsome Therapeutics Inc AXSM
Common Stock
|
2026-01-21 | Sell | 7,500 | $184.44 | 1,383,300 |
|
Axsome Therapeutics Inc AXSM
Common Stock
|
2026-01-21 | Option exercise | 7,500 | $70.73 | 530,475 |
|
Axsome Therapeutics Inc AXSM
Stock Option (Right to Buy) · derivative
|
2026-01-21 | Option exercise | 7,500 | $0.00 | |
|
Axsome Therapeutics Inc AXSM
Performance Stock Units · derivative
|
2025-02-24 | Grant | 7,740 | $0.00 | |
|
Axsome Therapeutics Inc AXSM
Employee Stock Option (Right to Buy) · derivative
|
2025-02-21 | Grant | 7,816 | $0.00 | |
|
Axsome Therapeutics Inc AXSM
Restricted Stock Units · derivative
|
2025-02-21 | Grant | 7,740 | $0.00 |